Immunocore Limited, a T Cell Receptor (TCR) biotechnology company focused on delivering first-in-class biological therapies that have the potential to transform lives of people with serious diseases, has entered into a new partnership with Genentech, a member of the Roche Group, to expand an existing discovery collaboration. Genentech and Immunocore will now co-develop Immunocore’s therapeutic…